Presence of impaired insulin secretion and insulin resistance in normoglycemic male subjects with family history of type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 60, Issue 2, 2003, Pages 95-103

  Ryder, Elena ^a   Gómez, Maria E ^a   Fernández, Virginia ^a   Campos, Gilberto ^a   Morales, Luz M ^a   Valbuena, Humberto ^a   Raleigh, Xiomara ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Disposition index; Ethnicity; Family history of diabetes; Insulin resistance; Insulin secretion; Obesity

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 0037405487     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(02)00282-6     Document Type: Article

References (26)

1. Gerich J.E. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocrinol. Rev. 19:1998;490-503.
2. Matthews D.R., Hosker J.P., Rudenski A.S., Neylor B.A., Treacher D.F., Turner R.L. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
3. Haffner S.M., Miettinen H., Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 20:1997;1087-1092.
4. Laakso M. How good a marker is insulin level for insulin resistance? Am. J. Epidemiol. 137:1993;959-965.
5. Philips D.I.W., Clark P.M., Osmond C.N. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance tests with specific measurements of insulin resistance and secretion. Diabetes Med. 11:1993;286-292.
6. Haffner S.M., Miettinen H., Gaskill S.P., Stern M.P. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes. 44:1995;1386-1391.
7. Guerrero-Romero F., Rodriguez-Moran M. Glucose intolerance is predicted by the high fasting insulin to glucose ratio. Diabetes Metab. 27:2001;117-121.
8. Efendic S., Luft R., Wajingot A. Aspects of the pathogenesis of type 2 diabetes. Endocrinol. Rev. 5:1984;395-410.
9. Kosaka K., Hagura R., Kuzuya T. Insulin responses in equivocal and definite diabetes with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes. 26:1977;944-952.
10. The Diabetes Prevention Program Research Group, The Diabetes Prevention Program, Baseline characteristics of the randomized cohort, Diabetes Care 23 (2000) 1619-1629.
11. Bergman R.N., Phillips L.S., Cobelli O. Physiological evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β-cell glucose sensitivity from the response of intravenous glucose. J. Clin. Invest. 68:1981;1456-1467.
12. Ryder E., Gómez M.E., Fernández V., et al. Patron de respuesta glucose-insulina durante una prueba de sobrecarga glucosada en individuos a riesgo para diabetes tipo 2. Invest. Clin. 42:2001;269-281.
13. Zimmet P.Z. Challenges in diabetes epidemiology: from west to the rest. Diabetes Care. 15:1992;232-252.
14. Elbein S.C., Hasstedt S.J., Wegner K., Kahn S.E. Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J. Clin. Endocrinol. Metab. 84:1999;1389-1403.
15. Haffner S.M., Gonzalez C., Miettinen H., Kennedy E., Stern M.P. A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care. 19:1996;1138-1141.
16. Fernandez-Castañer M., Biarnes J., Camps I., Ripolles J., Gomez N., Soler B. Beta cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Diabet. Med. 13:1996;953-959.
17. Matsumoto K., Mikaye S., Yano M., et al. Glucose tolerance, insulin secretion and insulin sensitivity in non-obese and obese Japanese subjects. Diabetes Care. 20:1997;1562-1568.
18. Grill V., Persson G., Carlsson S., et al. Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects. Diabetologia. 42:1999;15-23.
19. Nyholm B., Porkenssen N., Juhl C.B., et al. Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: evidence of beta cell dysfunction. Metabolism. 49:2000;896-905.
20. Pimenta W., Korytkowski M., Mitrakou A., et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. J. Am. Med. Assoc. 21:1995;1855-1861.
21. van Haeften T.W., Pimenta W., Mitrakou A., et al. Relative contributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia. Metabolism. 49:2000;1318-1325.
22. Saad M., Anderson R., Laws A., et al. A comparison between minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atheroesclerosis Study. Diabetes. 43:1994;1114-1121.
23. Hollenbeck C.B., Chen N., Chen Y.D.I., Reaven G.M. Relationship between the plasma insulin response to oral glucose and insulin stimulated glucose utilization in normal subjects. Diabetes. 33:1984;460-463.
24. Bergman R.N., Finegood D.T., Kahn S.E. The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes. Eur. J. Clin. Invest. 32:(Suppl. 3):2002;35-45.
25. Elbein S.C., Wegner K., Kahn S.E. Reduced β-cell compensation to the insulin resistance associated with obesity in members of Caucasian familial type 2 diabetic kindreds. Diabetes Care. 23:2000;221-227.
26. Haffner S.M., Mikkanen L., Festa A., Burke J.P., Stern M.P. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation. 101:2001;975-980.